Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01701466 | Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis | terminated | Phase 2 | 14 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT01262274 | Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer(Neo-ACET BC) | terminated | Phase 2 | 57 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER |
| 1 |
| May 21, 2015 |
| clinicaltrials |
| NCT00351858 | Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer(IV REXBC 02) | terminated | Phase 2 | 40 | Neovii BiotechINDUSTRY | 1 | May 1, 2015 | clinicaltrials |
| NCT01368263 | Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer | terminated | Phase 2 | 8 | Washington University School of MedicineOTHER | 1 | Apr 3, 2015 | clinicaltrials |
| NCT02008994 | Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer | terminated | Phase 2 | 5 | Sanford HealthOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT00132002 | Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer | terminated | Phase 2 | 14 | National Cancer Institute (NCI)NIH | 1 | Mar 19, 2015 | clinicaltrials |
| NCT00539968 | A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) | terminated | Phase 1 / Phase 2 | 5 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 5, 2015 | clinicaltrials |
| NCT00903006 | Trial of Fulvestrant, MK-0646, and Dasatinib for Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer | terminated | Phase 1 / Phase 2 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 2, 2015 | clinicaltrials |
| NCT00525161 | Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer | terminated | Phase 2 | 11 | Suleiman MassarwehOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01194908 | Re-expression of ER in Triple Negative Breast Cancers | terminated | Phase 1 / Phase 2 | 5 | Emory UniversityOTHER | 1 | Jan 26, 2015 | clinicaltrials |
| NCT01290718 | A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy. | terminated | Phase 2 | 4 | Hoffmann-La RocheINDUSTRY | 1 | Dec 17, 2014 | clinicaltrials |
| NCT01207102 | Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer | terminated | Phase 2 | 10 | Duke UniversityOTHER | 2 | Dec 15, 2014 | clinicaltrials |
| NCT00756470 | Phase II Neoadjuvant in Inflammatory Breast Cancer | terminated | Phase 2 | 15 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT01928615 | A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer(LISAH) | terminated | Phase 2 | 2 | Hoffmann-La RocheINDUSTRY | 1 | Sep 29, 2014 | clinicaltrials |
| NCT01272141 | A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer | terminated | Phase 2 | 5 | Emory UniversityOTHER | 1 | Sep 22, 2014 | clinicaltrials |
| NCT00570908 | Brain Mets - Capecitabine Plus Sunitinib and WBRT | terminated | Phase 2 | 12 | Baylor Breast Care CenterOTHER | 1 | Sep 18, 2014 | clinicaltrials |
| NCT00691912 | Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin(MyoPac) | terminated | Phase 2 | 26 | Claudia Lorenz-SchlüterOTHER | 1 | Sep 3, 2014 | clinicaltrials |
| NCT00524459 | Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 6 | Roswell Park Cancer InstituteOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT01430585 | Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer | terminated | Phase 2 | 14 | PfizerINDUSTRY | 4 | Aug 12, 2014 | clinicaltrials |
| NCT00576901 | A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer. | terminated | Phase 2 | 23 | Hoffmann-La RocheINDUSTRY | 1 | Aug 11, 2014 | clinicaltrials |
| NCT01363986 | A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer | terminated | Phase 2 | 3 | Hoffmann-La RocheINDUSTRY | 1 | Aug 11, 2014 | clinicaltrials |
| NCT01276054 | Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients. | terminated | Phase 2 | 4 | University of Southern CaliforniaOTHER | 1 | Aug 1, 2014 | clinicaltrials |
| NCT01151215 | Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer(MINT) | terminated | Phase 2 | 482 | AstraZenecaINDUSTRY | 18 | Jul 25, 2014 | clinicaltrials |
| NCT00930527 | Omega-3-Fatty Acid on Joint Symptoms Inducted by Aromatase Inhibitors | terminated | Phase 2 | 10 | Columbia UniversityOTHER | 1 | Jul 23, 2014 | clinicaltrials |
| NCT00744653 | Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects. | terminated | Phase 2 | 17 | Copenhagen University Hospital at HerlevOTHER | 1 | Jul 18, 2014 | clinicaltrials |
| NCT00709618 | Lapatinib + Vinorelbine in ErbB2 Overexpressing, First or Second Line Metastatic Breast Cancer Subjects | terminated | Phase 2 | 44 | GlaxoSmithKlineINDUSTRY | 1 | Jul 14, 2014 | clinicaltrials |
| NCT00165880 | An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine | terminated | Phase 2 | 62 | Eisai LimitedINDUSTRY | 5 | Jul 1, 2014 | clinicaltrials |
| NCT00128362 | Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer | terminated | Phase 2 | 478 | Tata Memorial HospitalOTHER_GOV | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00555477 | Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure | terminated | Phase 2 | 69 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 19, 2014 | clinicaltrials |
| NCT00079326 | Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer | terminated | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | Jun 2, 2014 | clinicaltrials |
| NCT00159458 | Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer | terminated | Phase 2 | 7 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00183963 | A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS) | terminated | Phase 2 | 4 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT01329640 | Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01) | terminated | Phase 2 | 9 | Instituto do Cancer do Estado de São PauloOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT01355523 | The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients(MELODY) | terminated | Phase 2 / Phase 3 | 54 | Melissa Voigt HansenOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT01332916 | Impact of Cancer on Memory Functioning: Understanding Disorders Using Approaches in Neuropsychology and Neuroimaging(CANMEM) | terminated | Phase 2 | 60 | Centre Francois BaclesseOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00517361 | Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer | terminated | Phase 2 | 11 | University of ChicagoOTHER | 1 | Apr 15, 2014 | clinicaltrials |
| NCT01131364 | Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients | terminated | Phase 1 / Phase 2 | 29 | Philogen S.p.A.INDUSTRY | 1 | Feb 25, 2014 | clinicaltrials |
| NCT01477060 | Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer | terminated | Phase 2 | 32 | Fondazione MichelangeloOTHER | 1 | Feb 20, 2014 | clinicaltrials |
| NCT00827567 | Trial of RAD001 in Triple Negative Metastatic Breast Cancer | terminated | Phase 2 | 6 | Milton S. Hershey Medical CenterOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00903656 | Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy | terminated | Phase 2 | 24 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Dec 24, 2013 | clinicaltrials |
| NCT00674206 | A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer | terminated | Phase 2 | 6 | Emory UniversityOTHER | 1 | Dec 12, 2013 | clinicaltrials |
| NCT00118053 | Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer | terminated | Phase 2 | 5 | University of Medicine and Dentistry of New JerseyOTHER | 1 | Nov 20, 2013 | clinicaltrials |
| NCT00003432 | Immunotherapy in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 4 | Duke UniversityOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01531764 | BIBW 2992 (Afatinib) and Vinorelbine | terminated | Phase 2 | 2 | University of MagdeburgOTHER | 1 | Oct 18, 2013 | clinicaltrials |
| NCT00726180 | Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer | terminated | Phase 1 / Phase 2 | 1 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 15, 2013 | clinicaltrials |
| NCT00147550 | MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma. | terminated | Phase 1 / Phase 2 | 79 | PfizerINDUSTRY | 1 | Sep 13, 2013 | clinicaltrials |
| NCT00104624 | Docetaxel in Treating Older Women With Metastatic Breast Cancer | terminated | Phase 2 | 53 | UNICANCEROTHER | 3 | Sep 4, 2013 | clinicaltrials |
| NCT01301040 | Early Cardiac Toxicity of Adjuvant CT in Elderly BC. | terminated | Phase 2 | 2 | Jules Bordet InstituteOTHER | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00476827 | A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain | terminated | Phase 2 | 16 | Duke UniversityOTHER | 1 | Jul 17, 2013 | clinicaltrials |
| NCT00674557 | Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer | terminated | Phase 2 | 111 | Cancer Research UKOTHER | 1 | Jul 10, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 25, 2015source: clinicaltrials